One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl-Reference-Cited by-同舟云学术

One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl

Published:2020-08-27 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Oogi Satomi,Nakakura Shunsuke,Terao Etsuko,Fujisawa Yasuko,Tabuchi Hitoshi,Kiuchi Yoshiaki

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference22 articles.

1. Glaucoma treatment: by the highest level of evidence;Heijl A;Lancet,2015

2. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial;Garway-Heath DF;Lancet,2015

3. Prostaglandin-associated periorbitopathy. a postmarketing surveillance observation. (2011). https://glaucomatoday.com/articles/2011-june/prostaglandin-associated-periorbitopathy?c4src=issue:feed.

4. Prostaglandin associated periorbitopathy in patients using bimatoprost, latanoprost and travoprost;Kucukevcilioglu M;Clin Exp Ophthalmol,2014

5. Latanoprost-induced prostaglandin-associated periorbitopathy;Tan J;Optom Vis Sci,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latanoprostene Bunod 0.024% w/v Treatment of Open-anlge Glaucoma: Short-term Effects, Safety, and Changes in Ocular Blood;Journal of the Korean Ophthalmological Society;2023-10-15

2. Influence of 0.002% Omidenepag Isopropyl on Intraocular Pressure and the Cornea in Normal Tension Glaucoma;Journal of Glaucoma;2022-12-21

3. Grand Challenges and Opportunities in Surgical Ophthalmology: Together for a Shared Future;Frontiers in Ophthalmology;2022-07-04

4. Emerging drugs for the treatment of glaucoma: a review of phase II & III trials;Expert Opinion on Emerging Drugs;2022-07-03

5. Periocular Adverse Reactions to Omidenepag Isopropyl;American Journal of Ophthalmology;2022-05